Physician profile
Richard Young
NPI 1619043601
$1,707.92
in general payments reported to CMS, 2019-2025
10 companies · $543 in 2025
The $543 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $193 · 2021: $98.00 · 2022: $259 · 2023: $202 · 2024: $253 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $542.07 | 2019-2025 | Precision7 |
| Bausch & Lomb Americas INC. | $298.83 | 2023-2025 | Xiidra, Miebo, Infuse |
| Tarsus Pharmaceuticals, INC. | $225.69 | 2024-2025 | Xdemvy |
| Visioneering Technologies, INC. | $172.60 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.00 | 2019-2020 | |
| Oyster Point Pharma, INC. | $117.76 | 2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $115.96 | 2022 | |
| Sight Sciences, INC. | $36.31 | 2023-2024 | Tearcare System, Omni Surgical System |
| Tearlab Corp | $35.19 | 2020 | |
| Lombart Brothers, INC. | $13.51 | 2025 | Opd-III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.